Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Bedranol

Bedranol
In stock
10mg · 20mg · 40mg · 80mg
from 17,11 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
32,14 £26,78 £
0,89 £ per tablet

In brief

  • In our pharmacy, you can buy Bedranol without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
  • Bedranol (propranolol) is used for hypertension, angina, arrhythmias, migraine prophylaxis, essential tremor, post‑MI secondary prevention and infantile haemangioma; it is a non‑selective beta‑adrenergic blocker that reduces heart rate, myocardial contractility and sympathetic effects.
  • Usual doses vary by condition: hypertension often starts at 40 mg twice daily (adjust to 120–240 mg/day), angina 80–320 mg/day, arrhythmias 10–30 mg 3–4 times daily, migraine prophylaxis 80–240 mg/day, essential tremor 40 mg twice daily up to 320 mg/day; post‑MI 180–240 mg/day; infantile haemangioma dosing begins at 0.5 mg/kg twice daily titrating as recommended.
  • Forms of administration include oral tablets, modified‑release capsules (e.g. Bedranol SR), oral solution (e.g. Hemangiol for infants) and intravenous ampoules for hospital use.
  • Oral immediate‑release propranolol usually begins to take effect within 30–60 minutes (peak 1–4 hours); extended‑release forms may take 2–4 hours to show full effect; IV onset is within minutes.
  • The duration of action is generally about 6–12 hours for immediate‑release formulations; extended‑release products provide once‑daily coverage up to 24 hours, while IV effects are shorter and dose‑dependent.
  • Avoid excessive alcohol: alcohol can increase drowsiness, dizziness and the risk of low blood pressure when taking propranolol and should be used with caution.
  • The most common side effect is fatigue.
  • Would you like to try Bedranol without a prescription?

Basic Bedranol information

  • INN (international nonproprietary name): Propranolol (pro-PRAN-oh-lol).
  • Brand names available in the United Kingdom: Bedranol SR; Inderal LA; Hemangiol (oral solution for infantile haemangioma); generic propranolol.
  • ATC code: C07AA05 — C07 = beta blocking agents, AA = non-selective beta blockers, 05 = propranolol.
  • Forms and dosages: Tablets commonly 10 mg, 40 mg, 80 mg and 160 mg, extended‑release (LA/XL/ER) forms and an oral solution (Hemangiol 3.75 mg/mL for infants), and IV ampoules 1 mg/mL for hospital use.
  • Manufacturers in the United Kingdom: AstraZeneca, Teva, Sandoz and other generic manufacturers.
  • Registration status in the United Kingdom: Prescription-only medicine (POM); licensed preparations for oral and IV use.
  • OTC / Rx classification: Prescription-only medicine (POM); supply requires a valid prescription.

Critical warnings, restrictions and immediate patient protection

High‑risk groups (elderly, pregnancy, chronic illness)

Priority safety summary: Propranolol is a prescription-only medicine with absolute contraindications including asthma or bronchospasm, severe bradycardia, high‑degree atrioventricular block (unless a pacemaker is present), uncompensated heart failure and known hypersensitivity to propranolol or excipients.

Use extreme caution in pregnancy and breastfeeding and ensure a documented risk/benefit discussion when used in these circumstances.

Elderly patients and those with hepatic or renal impairment should start at lower doses, titrate slowly and be monitored more closely for bradycardia and hypotension.

Patients with diabetes, peripheral vascular disease or a history of severe allergic reactions also require individualised assessment.

  • Baseline screening checklist: Record pulse and blood pressure before starting treatment.
  • Ask about respiratory history and previous asthma or wheeze.
  • Review current medicines for interactions, including other antihypertensives and interactions with insulin or oral antidiabetics.
  • Check diabetes history and advise glucose monitoring if appropriate.

Interaction with activities (driving, workplace safety under UK law)

Propranolol can cause dizziness, fatigue and blurred vision, particularly during dose titration or initiation.

Advise patients not to drive or operate heavy machinery until they know how propranolol affects them.

Record that driving and workplace safety counselling was given in the patient medication record (PMR).

Can I drive after taking it in the UK?

Short answer: Not until you know how it affects you.

If you experience dizziness, syncope, blurred vision or severe fatigue do not drive and seek clinical advice.

If a clinician advises it, inform the DVLA per their guidance on fitness to drive.

  • Contraindications (quick list): Asthma/bronchospasm, severe bradycardia, high‑degree AV block (unless pacemaker), uncompensated heart failure, known hypersensitivity.
  • Urgent symptoms checklist: Worsening breathlessness, severe chest pain, fainting/syncope, marked slow pulse, severe wheeze — seek emergency care.

Usage basics: INN, UK brands and legal classification

INN and brand names available in the UK

The International Nonproprietary Name is propranolol (pro-PRAN-oh-lol).

Common UK brands include Inderal and multiple generic propranolol products supplied by licensed manufacturers.

Formulations available in the UK include immediate‑release tablets (10 mg, 40 mg, 80 mg, 160 mg), modified‑release capsules (Bedranol SR, Inderal LA and generics) and the licensed oral solution Hemangiol for infantile haemangioma.

IV ampoules (1 mg/mL) are reserved for hospital use in emergencies.

Brand Formulation Typical doses
Inderal Tablets 10 mg, 40 mg, 80 mg, 160 mg
Bedranol SR / Inderal LA Extended‑release capsules/tablets 60 mg, 80 mg, 120 mg, 160 mg (once daily options)
Hemangiol Oral solution Weight‑based infant dosing
Generic propranolol Tablets, oral solution, IV ampoules Varies by product; 10–160 mg tablets and 1 mg/mL IV ampoules

Legal classification (POM, P, GSL) and NHS context

Propranolol is a prescription-only medicine (POM) in the UK.

Prescriptions are issued by GPs or hospital specialists and dispensed by community pharmacies when a valid prescription is produced.

When ordering on the NHS use an FP10 or NHS electronic prescription as applicable; pharmacists should verify MHRA licensing and local formulary preference.

INN
Propranolol — the generic name used in prescriptions and clinical guidance.
Brand
Bedranol SR, Inderal LA, Hemangiol and many generics supplied by recognised manufacturers.
Formulation
Immediate release tablets, extended‑release (LA/XL/ER), oral solution and IV ampoules for hospital use.

Dosing guide

Standard regimens (NHS‑aligned starting doses)

Hypertension commonly starts at 40 mg twice daily, adjusting as needed up to typical maintenance ranges.

Migraine prophylaxis is usually 80–240 mg/day in divided doses depending on response and tolerance.

Angina treatment typically ranges from 80–320 mg/day in divided doses according to symptoms and exercise tolerance.

Arrhythmias can be treated with 10–30 mg three to four times daily depending on rhythm control needs.

Secondary prevention after myocardial infarction often uses 180–240 mg/day in divided doses as tolerated.

For infantile haemangioma follow Hemangiol licence dosing, starting at 0.5 mg/kg twice daily and titrating to a maintenance dose of 1.5 mg/kg twice daily under paediatric supervision.

Condition Typical starting dose Titration notes
Hypertension 40 mg twice daily Increase gradually; monitor BP and HR
Migraine prophylaxis 80–240 mg/day (divided) Assess benefit after several weeks
Angina 80–320 mg/day (divided) Titrate to symptom control and tolerance
Arrhythmias 10–30 mg 3–4× daily Consider ECG monitoring if conduction disease suspected
Post‑MI 180–240 mg/day (divided) Start early post‑infarct if haemodynamically stable

Adjustments for comorbidities

Start at lower doses and titrate slowly in elderly patients and those with hepatic impairment because propranolol is hepatically metabolised.

Reduce dose for low body weight or frailty and monitor heart rate and blood pressure closely.

Obtain a baseline ECG when conduction disease is suspected or when interacting drugs that affect AV conduction are in use.

What if I miss a dose?

Take the missed dose as soon as you remember unless the next scheduled dose is near, in which case skip the missed dose.

Do not double up doses to make up for a missed tablet and contact your GP or pharmacist if unsure.

  • Monitoring triggers: Symptomatic bradycardia, symptomatic hypotension, new breathlessness, syncopal episodes — review urgently.
  • Dose titration checklist: Baseline BP/HR, review at 1–2 weeks after change, repeat at 6–12 weeks and as clinically indicated.

Interaction chart: food, drink and common drug conflicts

Food and drink interactions

Alcohol may increase sedation and the risk of hypotension when taking propranolol.

Caffeine intake can alter symptom control and may interact with anxiety‑related effects; advise moderation and consistent intake patterns.

There are no major food absorption restrictions, but taking propranolol with or after food can improve gastrointestinal tolerance for some patients.

  • Avoid or moderate alcohol intake due to increased sedation and blood pressure effects.
  • Keep caffeine intake consistent to avoid fluctuating tremor or palpitations.

Common drug conflicts

Propranolol interacts with several drug classes and requires vigilance when co‑prescribing.

Combination with other antihypertensives can cause additive hypotension and require dose adjustments and monitoring.

Concurrent use with non‑dihydropyridine calcium channel blockers increases the risk of marked bradycardia or AV block and should be avoided or closely supervised.

Other interactions of note include digoxin and certain antiarrhythmics, drugs that inhibit or induce hepatic CYP enzymes, and antidiabetic medicines where hypoglycaemia can be masked.

Drug / drug class Potential effect Action
Other antihypertensives Additive hypotension Monitor BP, adjust doses as needed
Calcium channel blockers (verapamil, diltiazem) Bradycardia, AV block Avoid combination or monitor ECG and HR closely
Digoxin Increased bradycardic effect Monitor pulse and consider ECG
Insulin / oral hypoglycaemics Masking of hypoglycaemia symptoms Increase glucose monitoring; patient education
CYP inhibitors / inducers Altered propranolol levels Consider dose adjustment and monitoring

Report suspected adverse reactions via the MHRA Yellow Card scheme to support pharmacovigilance.

Legal status and availability in the UK

In our online pharmacy, Bedranol is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Mechanism of action and pharmacology

Simplified explanation for patients

Propranolol is a non‑selective beta‑blocker that blocks both β1 and β2 adrenergic receptors.

It reduces heart rate and cardiac output and dampens sympathetic symptoms such as tremor and palpitations.

Because it crosses the blood–brain barrier, it can affect sleep patterns and mood in some people.

Clinical/pharmacokinetic terms for clinicians

Propranolol has high hepatic metabolism and variable oral bioavailability due to first‑pass metabolism.

Extended‑release formulations provide once‑daily dosing and more stable plasma levels compared with immediate‑release tablets.

IV preparations (1 mg/mL) are used in acute hospital settings for rapid control of arrhythmia or blood pressure in emergencies.

Non‑selective
Blocks β1 and β2 receptors, affecting heart, lungs and peripheral vasculature.
Bioavailability
Variable due to hepatic first‑pass; adjust doses in liver impairment.
ER formulations
Provide smoother plasma concentrations and once‑daily adherence benefits.

Indications and common off‑label uses

MHRA‑approved indications and NHS uses

Licensed indications include hypertension, angina, certain arrhythmias, migraine prophylaxis, essential tremor and secondary prevention after myocardial infarction.

Hemangiol oral solution is licensed for infantile haemangioma and is dosed by weight in paediatric practice.

Off‑label practices in NHS and private care

Common off‑label uses include situational or performance anxiety where single low doses may be used for acute symptom control.

Other specialist uses can include adjunct therapy in portal hypertension and selected neuropathic symptom management when other options are unsuitable.

  • Licensed uses: Hypertension, angina, arrhythmias, migraine prophylaxis, essential tremor, post‑MI prevention, infantile haemangioma (Hemangiol).
  • Common off‑label uses: Performance anxiety (single‑dose use), adjuncts in specific gastroenterology cases, selective neuropathic symptoms.

Alternatives matrix and NHS prescribing choices

NHS prescribing alternatives (comparison table)

Drug Beta‑selectivity Typical uses Pros Cons
Atenolol Cardioselective (β1) Hypertension, angina Less central penetration Longer half‑life but not ideal for asthma patients
Metoprolol Cardioselective (β1) Angina, heart failure, arrhythmias Widely used in cardiology May require twice‑daily dosing for some formulations
Bisoprolol Cardioselective (β1) Heart failure, hypertension Cardioselectivity useful in respiratory disease Still requires monitoring for bradycardia
Carvedilol Non‑selective with alpha block Heart failure, hypertension Useful in heart failure with additional vasodilatory effect May cause more hypotension

Pros and cons checklist when switching

  • Consider cardioselective agents for patients with asthma or COPD risk.
  • Evaluate renal and hepatic function when choosing and dosing alternatives.
  • Assess adherence preferences for once‑daily vs multiple daily dosing.
  • Review tolerability history (fatigue, vivid dreams) and patient preference.

When reviewing repeat prescriptions, clinicians should perform an indication review, check side‑effects, record BP and HR, and request ECG if conduction disease is suspected.

Common patient questions and brief answers

  • Can I stop propranolol suddenly? No — taper under clinician supervision to avoid rebound hypertension or tachycardia.
  • Does it cause weight gain? Not a primary effect; some patients report appetite or symptom changes — monitor weight if concerned.
  • Is it safe in diabetes? Use with caution — propranolol can mask hypoglycaemia symptoms; increase glucose monitoring.
  • Can I drink alcohol? Moderate alcohol increases sedation and hypotension risk; avoid excess.

Registration, regulation and reporting

MHRA approval and licensing framework

Propranolol products supplied in the UK are regulated by MHRA licensing conditions, and generics must meet licence requirements.

Prescribe licensed doses when possible and document rationale and informed consent when prescribing off‑label.

NHS prescribing framework and pharmacovigilance

Report adverse reactions via the MHRA Yellow Card scheme and follow local formulary guidance for preferred brands.

  • Checklist for clinicians: confirm product licence, document consent for any off‑label use, and report suspected adverse events via Yellow Card.

Storage, transport and household handling

Household storage in UK conditions

Store propranolol at room temperature, typically 15–25°C, away from moisture, heat and direct light.

Keep oral solutions tightly closed and retain medicines in their original packaging to preserve stability and leaflets.

Avoid storing medicines in bathrooms or near windows where UK damp conditions may affect them.

Pharmacy and travel transport guidance

Advise patients to carry medicines in original containers and to bring a copy of the prescription or e‑prescription when travelling.

Keep controlled temperature items out of very hot conditions and carry essential medicines in hand luggage during flights.

  • Household do’s: Store at recommended temperature, keep out of sight and reach of children, check expiry dates before use.
  • Travel checklist: carry‑on medicines, prescription copy, emergency contact and pharmacist contact details.

Practical guidelines for proper use and pharmacist counselling

UK pharmacist counselling style and key messages

On supply confirm the indication and review for absolute contraindications such as asthma, heart block and severe bradycardia.

Check concomitant medicines and explain common side effects such as fatigue, vivid dreams and cold extremities.

Advise patients on missed dose rules and what to do in case of suspected overdose — seek immediate medical attention.

NHS patient safety advice and monitoring plan

Recommend baseline blood pressure and heart rate recording, and a review after dose changes at 1–2 weeks and again at 6–12 weeks.

Consider ECG monitoring if conduction disease is suspected or if interacting drugs are started.

For infant haemangioma ensure paediatric follow‑up and strict weight‑based dosing under specialist supervision.

  • Pharmacist counselling checklist: indication, contraindications, concomitant drugs, side‑effects, driving advice, missed dose and overdose actions.
  • Suggested monitoring schedule: baseline, 1–2 weeks after start/change, 6–12 weeks, then periodic reviews.

Delivery across the United Kingdom

City Region Delivery time
London England 9–21 days
Birmingham England 9–21 days
Manchester England 9–21 days
Glasgow Scotland 9–21 days
Leeds England 9–21 days
Edinburgh Scotland 9–21 days
Bristol England 9–21 days
Liverpool England 9–21 days
Sheffield England 9–21 days
Cardiff Wales 9–21 days
Belfast Northern Ireland 9–21 days
Newcastle Upon Tyne England 9–21 days
Nottingham England 9–21 days
Southampton England 9–21 days

Related products